Filing Details
- Accession Number:
- 0001946439-24-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-12 17:08:37
- Reporting Period:
- 2024-12-11
- Accepted Time:
- 2024-12-12 17:08:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1946439 | Krista Davis | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | Svp, Chief Hr Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-11 | 1,000 | $60.00 | 49,059 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024.
Billionaire Hedge Funds
